Prikladnaia Biokhimiia i Mikrobiologiia 2008-01-01

[Synthesis of 2-chloro-2'-deoxyadenosine by microbiological transglycosylation using a recombinant Escherichia coli strain].

S A Taran, K N Verevkina, T Z Esikova, S A Feofanov, A I Miroshnikov

Index: Prikl. Biokhim. Mikrobiol. 44(2) , 181-6, (2008)

Full Text: HTML

Abstract

Cladribine (2-chloro-2'-deoxyadenosine) was synthesized using intact cells of the recombinant Escherichia coli strain producing Geobacillus stearothermophilus B-2194 thermostable purine-nucleoside phosphorylase II (EC 2.4.2.1). Use of the cells containing this thermostable enzyme allowed the process to be conducted at a temperature of 70 degrees C, which provided the maximal concentrations of sparingly soluble substrates. The best results were obtained with 2-chloroadenine as a modified base. The highest yield of the target 2-chloro-2'-deoxyadenosine (up to 95% in the case of deoxyguanosine) was reached when using 2'-deoxypurines as donors of deoxyribose. Use of thymidine for these purposes required its considerable molar excess over 2-chloroadenine (up to 6 : 1), which is connected with a nonoptimal amount of endogenous thymidine phosphorylase, necessary for synthesis of deoxyribose-1-phosphate, in the transglycosylation reaction.


Related Compounds

Related Articles:

Cytotoxicity and pharmacokinetics of cladribine metabolite, 2-chloroadenine in patients with leukemia.

2004-07-16

[Cancer Lett. 210(2) , 171-7, (2004)]

Age-related changes in ischemic tolerance in male and female mouse hearts.

2005-02-01

[J. Mol. Cell. Cardiol. 38(2) , 245-56, (2005)]

Metabolism and cytotoxic effects of 2-chloroadenine, the major catabolite of 2-chloro-2'-deoxyadenosine.

2000-05-15

[Biochem. Pharmacol. 59(10) , 1237-43, (2000)]

Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor increases pentylenetetrazol seizure threshold in mice: possible involvement of adenosinergic mechanism.

2008-01-01

[Epilepsy Res. 78(1) , 60-70, (2008)]

Stability and analysis of 2-chloro-2'-deoxyadenosine, 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine and 2-chloroadenine in human blood plasma.

1997-06-01

[Anticancer Drugs 8(5) , 445-53, (1997)]

More Articles...